Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of 9MW1911 in chronic obstructive pulmonary disease
CTR20252324Phase 2Active
- Sponsor
- Maiwei Biotech
- Start
- Jul 2025
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of 9MW1911 in chronic obstructive pulmonary disease (COPD), sponsored by Maiwei Biotech. Started Jul 2025; status: active.
02
Drugs
9MW1911
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20252324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252324.